Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde
- PMID: 9238032
- PMCID: PMC23062
- DOI: 10.1073/pnas.94.16.8652
Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde
Abstract
The spectrum of mutations induced by the naturally occurring DNA adduct pyrimido[1,2-alpha]purin-10(3H)-one (M1G) was determined by site-specific approaches using M13 vectors replicated in Escherichia coli. M1G was placed at position 6256 in the (-)-strand of M13MB102 by ligating the oligodeoxynucleotide 5'-GGT(M1G)TCCG-3' into a gapped-duplex derivative of the vector. Unmodified and M1G-modified genomes containing either a cytosine or thymine at position 6256 of the (+)-strand were transformed into repair-proficient and repair-deficient E. coli strains, and base pair substitutions were quantitated by hybridization analysis. Modified genomes containing a cytosine opposite M1G resulted in roughly equal numbers of M1G-->A and M1G-->T mutations with few M1G-->C mutations. The total mutation frequency was approximately 1%, which represents a 500-fold increase in mutations compared with unmodified M13MB102. Transformation of modified genomes containing a thymine opposite M1G allowed an estimate to be made of the ability of M1G to block replication. The (-)-strand was replicated >80% of the time in the unadducted genome but only 20% of the time when M1G was present. Correction of the mutation frequency for the strand bias of replication indicated that the actual frequency of mutations induced by M1G was 18%. Experiments using E. coli with different genetic backgrounds indicated that the SOS response enhances the mutagenicity of M1G and that M1G is a substrate for repair by the nucleotide excision repair complex. These studies indicate that M1G, which is present endogenously in DNA of healthy human beings, is a strong block to replication and an efficient premutagenic lesion.
References
-
- Ames B N, Gold L S. Mutat Res. 1991;250:3–16. - PubMed
-
- Marnett L J, Burcham P C. Chem Res Toxicol. 1993;6:771–785. - PubMed
-
- Lindahl T. Nature (London) 1993;362:709–715. - PubMed
-
- Singer B, Bartsch H. The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis. Lyon: International Agency for Research on Cancer; 1986.
-
- Barbin A, El Ghissassi F, Nair J, Bartsch H. Proc Am Assoc Cancer Res. 1993;34:136. (abstr.).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
